Hints and tips:
Related Special Reports
...This month, Roche agreed to buy Carmot Therapeutics, a US start-up with potential GLP-1 drugs, for up to $3.1bn....
...Analysts at Barclays said the acquisition was “in line with GSK’s strategy of adding bolt-on assets in its core therapeutics areas” such as respiratory medicines, referencing its $2bn agreement last April...
...“There’s a growing recognition, when you think about UK plc, that growth will come from the industries of the 21st century: AI, quantum computing, advanced therapeutics,” he observes....
...However, this may not fully allay lingering concerns that the group’s portfolio is too concentrated in a handful of therapeutic areas....
...legal team have played a crucial role in negotiating partnership deals with businesses such as biotech company Amgen, which involves Amgen paying $50mn upfront to fund discovery and creation of protein therapeutics...
...“It feels like they are pivoting back slightly into their historic therapeutic areas of success,” the healthcare investor said....
...Iain McGill, chief executive of UK biotech start-up Quell Therapeutics, received a call in New York on Thursday warning that the bank was in peril....
...“Typically the market looks at drug companies by key franchises, like an individual drug or therapeutic area,” said Dani Saurymper, portfolio manager at AstraZeneca investor Pacific Asset Management....
...Jane Osbourn, chief scientific officer at another biotech, Alchemab Therapeutics, was one of the scientists giving up their evenings and weekends to hunt for a Covid-19 antibody....
...The flurry of deals on Monday comes after drugmakers struck two larger ones last month, including California-based Amgen acquiring Horizon Therapeutics for $28.3bn, including debt, after winning a three-way...
...Earlier this month, Amgen bought Horizon Therapeutics for $28bn....
...The trust first invested in Intarcia Therapeutics, a US biopharma firm, through a promissory note. However, the company went bankrupt in 2020 and wiped out Scottish Mortgages’ $15mn investment....
...He became fascinated by the work of psychiatrists who had explored the therapeutic potential of psychedelics in the 1950s and early 1960s, until the experiments ground to a halt amid a political backlash...
...It also works with German drugmaker Boehringer Ingelheim and Juno Therapeutics and Beam Therapeutics in the US....
...Daniele Piergentili, president of Croda’s life sciences arm, said the technology “offers significant potential for the safe and efficient delivery of next-generation vaccines and therapeutic drugs”....
...Other businesses in the Future Fund portfolio include Epsilogen, a London-based developer of novel therapeutic antibodies to treat cancer, and nDreams, a virtual reality games developer....
...Shattock said the prospect of more therapeutic applications “adds to the technology’s great potential”....
...June Raine, the MHRA’s chief executive, said: “This is yet another therapeutic that has been shown to be effective at protecting those most vulnerable to Covid-19, and signals another significant step forward...
...The UK pharma group will pay Boston-based biotech iTeos Therapeutics $625m upfront for the collaboration on an antibody treatment in phase 2 trials for advanced solid tumours, known as EOS-448....
...McNamara, a former executive at Novartis and P&G, said GSK’s therapeutic oral health brands were a prime example of “a company that combines really great [fast-moving consumer goods] skills and consumer...
...Earlier this year, chief executive Jacek Olczak announced a “beyond nicotine” strategy that includes a move into inhaled therapeutics....
...Biopharmaceutical start-up eFFECTOR Therapeutics expected to receive at least $100m in proceeds from its merger with Locust Walk Acquisition, a Spac that raised $175m when it listed in January....
...The medical business was the only division where sales declined, with Covid-19 delaying the installation of larger therapeutic and diagnostic equipment in hospitals....
...But Vaccitech’s “real focus” was therapeutics, he said, with an early clinical trial of a lung cancer drug due to start in the middle of this year, as part of a collaboration with Cancer Research, and data...
...That new site will also be used by Juno Therapeutics, a subsidiary of Bristol-Myers Squibb, with which the group signed a deal in March....
International Edition